1-50418773-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_032110.3(DMRTA2):c.1521T>A(p.Asp507Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000189 in 1,585,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032110.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.00000498 AC: 1AN: 200748Hom.: 0 AF XY: 0.00000893 AC XY: 1AN XY: 111970
GnomAD4 exome AF: 0.00000140 AC: 2AN: 1433616Hom.: 0 Cov.: 30 AF XY: 0.00000281 AC XY: 2AN XY: 712140
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2021 | The c.1521T>A (p.D507E) alteration is located in exon 3 (coding exon 2) of the DMRTA2 gene. This alteration results from a T to A substitution at nucleotide position 1521, causing the aspartic acid (D) at amino acid position 507 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at